CymaBay Therapeutics, Inc. announced the appointment of Dr. Éric Lefebvre to its Board of Directors. Dr. Lefebvre is serving as Chief Medical Officer of Pliant Therapeutics, Inc., a biopharmaceutical company, where he has served as such since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development at Allergan plc, a global pharmaceutical company, from November 2016 until April 2018.
CymaBay Therapeutics, Inc.
Equities
CBAY
US23257D1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.25% | 114B | |
+11.49% | 104B | |
-13.61% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.67% | 17.89B | |
+7.92% | 14.28B | |
+34.93% | 12.55B |